SNS-032 Completed Phase 1 Trials for Tumor Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00292864
Safety Assessment of One-hour Infusions of SNS-032 for the Treatment of Select Advanced Solid Tumors